A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis

Status Completed

Clinical Trial Summary

The purposes of this study is to demonstrate the analgesic efficacy of flurbiprofen 8.75 mg lozenge compared to its vehicle lozenge and to demonstrate the safety of the flurbiprofen lozenge throughout the course of treating sore throat due to acute pharyngitis.

Clinical Trial Description

Per randomization to the treatments and under double-blind conditions, patients were instructed to suck 1 sugar-based, flavoured flurbiprofen 8.75 mg lozenge or 1 sugar-based, flavoured matching vehicle control/placebo lozenge and remained at the study center for a 2-hour observation period to assess their responses to the study medication during the initial 2-hour post-dose period. Patients were allowed a dose of rescue medication (acetaminophen 650mg), as needed, post-treatment dosing during the study.

After the initial 2 hours in the research center, patients were discharged with an outpatient diary to continue (while awake) to document hourly assessments of Sore Throat Pain Intensity Scale (STPIS), Difficulty Swallowing Scale (DSS), and Swollen Throat Scale (SwoTS) through 24 hours. They used the assigned lozenges as needed every 3-6 hours, up to 5 lozenges over 24 hours. A Follow-Up Visit was conducted for the 24-hour assessments.

Patients received additional study lozenges for use as needed (up to 5 lozenges per 24 hours) over the following 6 days, rescue medication (acetaminophen 650 mg) and a Diary to document their safety and efficacy assessments immediately before and postdose after each as-needed use of a lozenge for the remaining days in the 7-day treatment period. At the end of the 7-day trial, patients returned to the research center for final assessments, review of adverse events over the week, and discharge from the study. ;

Study Design

Related Conditions & MeSH terms

Pharyngitis

Clinical Trial Details

NCT number	NCT01048866
Study type	Interventional
Source	Reckitt Benckiser LLC
Contact
Status	Completed
Phase	Phase 3
Start date	November 2009
Completion date	March 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01453400` - Evaluate the Time of Pain Relief of Fast Acting Aspirin Versus Acetaminophen in Subjects Diagnosed With Sore Throat Pain	Phase 3
Completed	`NCT04016051` - Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections	Phase 3
Recruiting	`NCT01681667` - Tablet vs. Liquid Suspension Ibuprofen in the Relief of Pain	Phase 4
Completed	`NCT00527852` - Assessment of Flocked Swabs for the Identification of Group A Streptococcal Pharyngitis	N/A
Completed	`NCT02178293` - Ketoprofen Lysine Salt as Mouthwash in Acute Phlogosis of the Pharyngeal Cavity Versus Benzidamine Hydrochloride	Phase 4
Active, not recruiting	`NCT05127161` - Broad Implementation of Outpatient Stewardship	N/A
Withdrawn	`NCT02535962` - Probiotics and Corticosteroids for Treating Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA)	Phase 2
Not yet recruiting	`NCT02252419` - Combined Effect of Dexamethasone and Paracetamol for Postoperative Sore Throat	N/A
Completed	`NCT00798018` - Effect of Intra-cuff Lidocaine and Tetracaine on Tracheal Tube-induced Emergence Phenomena	N/A
Completed	`NCT00535093` - An Assessment of Rapid Streptococcal Tests in Community Clinics in Israel	N/A
Completed	`NCT00148499` - Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/Viralpharyngitis	Phase 3
Completed	`NCT00095368` - APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) for 10 Days in Patients With Strep Throat	Phase 3
Recruiting	`NCT06027593` - Using Electronically Derived Automated Reports of Appropriate Antibiotic Use to Inform Stewardship Interventions	N/A
Recruiting	`NCT03720301` - The Use of Osteopathic Medical Manipulation to Decrease the Incidence and Severity of Post-Operative Sore Throat	N/A
Completed	`NCT01361399` - Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold	Phase 3
Completed	`NCT01049334` - A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis	Phase 3
Completed	`NCT01398696` - Impact of Four Patient Information Leaflets (PIL) on Patient Behaviour	Phase 4
Completed	`NCT00547391` - Recurrent Throat Infections and Tonsillectomy	Phase 4
Completed	`NCT00242281` - APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat	Phase 3
Completed	`NCT01465009` - Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common Cold	Phase 4